As of 2025-07-20, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (48.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -8842.8%.
The range of the Relative Valuation is (48.03) - (45.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 18.0x | 17.7x |
| Forward P/E multiples | 18.9x - 22.4x | 20.1x |
| Fair Price | (48.03) - (45.80) | (48.09) |
| Upside | -8833.6% - -8426.5% | -8842.8% |
| Date | P/E |